A sample report by Clearstate

Unparalleled depth and actionable intelligence about South Korea’s in-vitro diagnostics market

The IVD market in South Korea reached US$1.0 billion in 2022. Over the next five years, growth is expected to increase by 2.2% CAGR with an ageing population and increased healthcare expenditure.

SARS-COV-2 rapid antigen tests and PCR tests volume will continue to decline in 2023 and 2024, but what will the post-pandemic recovery for other IVD test segments look like?

This sample report offers a glance at the granular insights and in-depth analysis awaiting you in the full Segment Trend Report about South Korea’s IVD market.